Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct;118(1):87-94.
doi: 10.1046/j.1365-2249.1999.01033.x.

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy

Affiliations

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy

A Giovannetti et al. Clin Exp Immunol. 1999 Oct.

Abstract

Expression of chemokine receptors and beta-chemokine production by peripheral blood mononuclear cells (PBMC) were determined in HIV-1-infected individuals before and after highly active anti-retroviral therapy (HAART) and their relationship to viral load, T cell phenotype and the expression of immunological activation markers was examined. We found that the expression of CCR5 is up-regulated in HIV-1-infected individuals while CXCR4 appears down-regulated on both CD4 and CD8 T cells compared with normal controls. These alterations are associated with the high levels of viral load. In addition, a relationship was observed between the degree of immune activation and chemokine receptor expression on T cells. However, after 3 months of combined anti-retroviral regimen, expression of CXCR4 significantly increased while CCR5 decreased when compared with pretherapy determinations. This was seen in strict association with a dramatic decrease of viral load and an increase of both CD45RA+/CD62L+ (naive) and CD45RA-/CD62L+ or CD45RA+/CD62L- (memory) T cells accompanied by a significant decrease of the expression of immune activation markers such as HLA-DR and CD38. At enrolment, both spontaneous and lectin-induced RANTES, macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta production by PBMC were higher in HIV-1-infected individuals compared with normal controls, although differences for MIP-1beta were not statistically significant. However, RANTES and MIP-1alpha production decreased during HAART at levels closer to that determined with normal controls, while MIP-1beta production was less consistently modified. These data indicate that the expression of chemokine receptors CCR5 and CXCR4 and the production of beta-chemokines are altered in HIV-infected individuals, and suggest that their early modifications during HAART reflect both the peripheral redistribution of naive/memory T cell compartments and the decrease in levels of T cell activation. Such modifications in the expression of host determinants of viral tropism and the production of anti-viral molecules may play a role in the emergence of virus variants when a failure of HAART occurs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Reciprocal modifications of CCR5 and CXCR4 chemokine receptor expression on CD4+ and CD8+ T cells during early peripheral repopulation induced by highly active anti-retroviral therapy (HAART). Four-colour flow cytometric analysis was performed with peripheral blood mononuclear cells (PBMC) from HIV-1-infected individuals or normal blood donors at enrolment (time 0) and 3 months after HAART (time 3). The following MoAbs were used: anti-CD4–allophycocyanin (APC), anti-CD8–peridinin chlorophyll protein (PerCP), anti-CCR5–PE clone 2D7 and anti-CXCR4–PE clone 12G5. The expression of CCR5 before therapy was significantly increased in both CD4+ (a) and CD8+ T cells (b), while the expression of CXCR4 in the same cell types was down-regulated (c and d, respectively) compared with controls (represented by a line on graphs). After 3 months of HAART, the percentage of CCR5-expressing CD4+ (a) and CD8+ T cells (b) was significantly diminished, while CXCR4 expression was consistently increased (c and d, respectively).
Fig. 2
Fig. 2
Modifications of spontaneous and lectin-induced β-chemokine production by peripheral blood mononuclear cells (PBMC) from HIV-1-infected individuals at enrolment (time 0) and 3 months after highly active anti-retroviral therapy (HAART) (time 3). Unstimulated (a) and phytohaemagglutinin (PHA)-induced (b) RANTES, macrophage inflammatory protein-1α (MIP-1α) and MIP-1β production was determined by ELISA in supernatants from PBMC short-term cultures performed with freshly collected blood samples from HIV-1-infected individuals or normal donors (controls). At enrolment, HIV-1-infected individuals produced higher levels of RANTES, MIP-1α and MIP-1β both spontaneously (a) and upon lectin-induction (b), compared with normal controls. However, both spontaneous and induced production of RANTES and MIP-1α consistently decreased after 3 months of HAART, reaching values closer to those detected in control individuals (a,b). MIP-1β lectin-induced production remained at the levels detected at enrolment (a,b).

Similar articles

Cited by

References

    1. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature. 1996;381:667–73. - PubMed
    1. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661–6. - PubMed
    1. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135–48. - PubMed
    1. Carroll RG, Riley JL, Levine BL, Blair PJ, St LD, June CH. The role of co-stimulation in regulation of chemokine receptor expression and HIV-1 infection in primary T lymphocytes. Semin Immunol. 1998;10:195–202. - PubMed
    1. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272:872–7. - PubMed

Publication types

MeSH terms